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Importance of heterogeneity in Porhyromonas gingivalis lipopolysaccharide
lipid A in tissue specific inflammatory signalling
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aDepartment of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; bDementia and Neurodegenerative Diseases
Research Group, Faculty of Clinical and Biomedical Sciences, School of Dentistry, University of Central Lancashire, Preston, UK
ABSTRACT
Lipopolysaccharide (LPS) of Porphyromonas gingivalis exists in at least two known forms,
O-LPS and A-LPS. A-LPS shows heterogeneity in which two isoforms designated LPS1,435/1,449
and LPS1,690 appear responsible for tissue-specific immune signalling pathways activation and
increased virulence. The modification of lipid A to tetra-acylated1,435/1,449 and/or penta-
acylated1,690 fatty acids indicates poor growth conditions and bioavailability of hemin.
Hemin protects P. gingivalis from serum resistance and the lipid A serves as a site for its
binding. The LPS1,435/1,449 and LPS1,690 isoforms can produce opposite effects on the human
Toll-like receptors (TLR) TLR2 and TLR4 activation. This enables P. gingivalis to select the
conditions for its entry, survival, and that of its co-habiting species in the host, orchestrating
its virulence to control innate immune pathway activation and biofilm dysbiosis. This review
describes a number of effects that LPS1,435/1,449 and LPS1,690 can exert on the host tissues
such as deregulation of the innate immune system, subversion of host cell autophagy,
regulation of outer membrane vesicle production, and adverse effects on pregnancy out-
come. The ability to change its LPS1,435/1,449 and/or LPS1,690 composition may enable P.
gingivalis to paralyze local pro-inflammatory cytokine production, thereby gaining access to
its primary location in periodontal tissue.
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Introduction
Porphyromonas gingivalis is considered to be a keystone
Gram-negative, anaerobic intracellular pathogen in adult
periodontitis [1]. It has a plethora of virulence factors [2]
of which lipopolysaccharide (LPS), gingipains, fimbriae,
hemagglutinins, and outer membrane vesicles (OMVs)
are of major importance. LPS is located in the outer
membrane of Gram-negative bacteria and is a potent
stimulator of host’s innate immune signal transduction
pathways in a tissue/cell-specific manner [3]. This is seen
in bone, epithelial cell barrier breakdown, and keratino-
cytes [4,5]. Historically, LPS has been thought to consist
of three variable and conserved regions [6,7]. These
include lipid A (common to all forms of LPS from
Gram-negative bacteria), which can consist of fatty acid
esters; these fatty acid esters in turn are either attached to
phosphorylated glucosamine disaccharides or 3-OH iso-
branched C17:0 and other fatty acids with amide-links to
both saccharide units in lipid A: a conserved core oligo-
saccharide that links lipid A to the O-antigen; and a
highly variable O-polysaccharide or O-antigen [8]
(Figure 1).
Of the LPS macromolecule, lipid A is responsible
for the endotoxic activities, and its recognition by
host cells leads to differential immuno-inflammatory
responses [4,7–9]. From LPS, it is the heterogeneity
within the A-LPS which represents the major viru-
lence factors that promote inflammation and bone
loss. Hence in immunological terms, the A-LPS het-
erogeneous forms represent ‘pathogen associated
molecular patterns’ (PAMPs) and have been exten-
sively studied for their role in the pathogenesis of
periodontitis (for a review, see Nichols et al. [10]),
however not without controversy. Whereas some stu-
dies reported that P. gingivalis LPS stimulates secre-
tion of pro-inflammatory cytokines [11], others
found contradictory results with regard to cytokine
release [5,12]. Besides, LPS acting as an agonist for
Toll-like receptor (TLR) TLR2 or as an antagonist
and/or agonist for TLR4 activation [13–16] added to
further contradiction. Although TLR2 activation by
P. gingivalis LPS is possible, the difference lies in the
form of LPS presented to the host. For example, the
protein-free LPS is unable to activate TLR2, whereas
the bound LPS on the live bacterium can mediate
TLR2 activation via a novel class of lipoprotein
lipase-sensitive molecules highlighting the impor-
tance of active infection [17]. In essence, and accord-
ing to Lasica et al. [18], the tightly associated or
covalently attached protein to LPS on live P. gingiva-
lis accounts for the TLR2 activation. In terms of bone
loss, in vitro and in vivo experiments have provided
conflicting data. For example, when P. gingivalis is
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co-cultured with bone cells in vitro, the effect on
bone resorbing cells appears to be mediated through
engagement of both TLR2 and TLR4 [15,19].
However, similar experiments conducted in experi-
mental animals orally infected with P. gingivalis pre-
dominantly show bone loss to be mediated by TLR2
[20–22]. If the in vivo data are confirmed in human
alveolar bone resorption mechanisms, this is another
example of P. gingivalis LPS lipid A heterogeneity
showing differential inflammatory signalling accord-
ing to tissue specificity.
P. gingivalis has two major forms of LPS, O-LPS
(Figure 1(a)) [23] and A-LPS (Figure 1(b)) [24–26].
O-LPS is a conventional O-antigen polysaccharide
found in most bacteria with Gram-negative charac-
teristics, and A-LPS is an anionic polysaccharide
(APS) (Figure 1(b)). Both O and A-LPS forms are
linked to lipid A. While the O-antigen repeating
polysaccharide unit of O-LPS contains →3)-α-D-
Galp-(1→6)-α-D-Glcp-(1→4)-α-L-Rha-(1→3)-β-D-
GalNAcp-(1→, the polysaccharide repeating unit of
A-LPS consists of a phosphorylated branched D-Man-
containing oligomer made up of an α1→6-linked D-
mannose backbone. To the latter branch of the back-
bone, α1→2-linked D-Man side chains of varying
lengths with one or two residues are attached at
position 2 [27].
In addition to the structural differences in P. gingi-
valis A-LPS mentioned above, a variety of different lipid
A structures have been reported [28,29]. These lipid A
structures, in the literature, are referred to as phos-
phorylated tetra-acylated and phosphorylated penta-
acylated proteins. The tetra-acylated form of A-LPS
has a molecular weight of 1,435 and 1,449 Da, and the
penta-acylated form of A-LPS has a molecular weight of
1,690 Da [30]. For clarity, the tetra-acylated form of
A-LPS has been designated LPS1,435/1,449 (Figure 1(c))
and the penta-acylated form LPS1,690 (Figure 1(d)) [30].
The role of these variable regions appears to involve
signalling pathway activation in various effector cells,
organs, and diseases (Table 1). It has to be stressed that
the heterogeneity is related to the bioavailability of
essential growth nutrients such as hemin [25], phos-
phate availability [31], and to an extent on temperature
[32]. The aim of this review is to assess the importance
of the heterogeneity in P. gingivalis LPS lipid A.
Lipid A phosphatase is required for
colonization and commensal overgrowth of
bacteria in periodontitis
P. gingivalis has the ability to change its A-LPS lipid A
phosphate composition (LPS1,435/1,449 or LPS1,690) in
response to differing environmental conditions. It is
Figure 1. Schematically shows two main forms of LPS (O-LPS and A-LPS) and their position on the outer cell wall (arrow). (a)
Section of P. gingivalis (FDC 381) demonstrated by transmission electron microscopy. Thick arrow points to lipid A with fatty acid
esters attached to phosphorylated glucosamine disaccharides and the O-antigen. The latter is O-LPS (with O-antigen tetra-
saccharide repeating units); (b) A-LPS (with surface anionic polysaccharide [APS] repeating units). There are two lipid As in A-LPS
as shown in (c) and (d). (c) A tetra-acylated form with two different molecular weights, hence two structures. (d) the penta-
acylated form.
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this property, which makes the bacterium highly adap-
table to different inflammatory niches. P. gingivalis can
produce A-LPS lipid A structures that are agonists
(LPS1,690) or antagonists (LPS1,435/1,449) to activation
of TLR4 [25,31,32] because under the influence of P.
gingivalis, it helps to create an inflammophilic environ-
ment for selection of its co-species and control any
competition. Despite the fact that phosphatases are
important for successful colonization of P. gingivalis,
Zenobia et al. [33] demonstrated in a rabbit ligature
model of experimental periodontitis that exposure of
the oral cavity to the mutant strains (with locked lipid
A structures) did not increase the microbial load. This
suggests that the mutant strains were unable to remo-
del their lipid A structure, which would otherwise be
capable of inducing a favourable co-inhabiting envir-
onment. This begs the question: why would P. gingiva-
lis change its lipid A phosphate composition? The
answer lies in the Zenobia et al. [33] study that detected
significant qualitative changes in the microbial compo-
sition from the mutant strains, in that all P. gingivalis
strains and their LPS preparations resulted in the devel-
opment of periodontitis. Furthermore, this keystone
bacterium even in its mutant form changed the lipid
A composition by utilizing the phosphatases from its
microenvironment. Hence, successful colonization
took place whereby the microbial load increased in
the rabbit ligature model of periodontitis [31]. These
results suggest that not only disruption of host home-
ostasis is highly plausible but also that an evolving
commensal microbial community can become dysbio-
tic even under the influence of a mutant form of P.
gingivalis resulting in disease.
The lipid A structure is modulated by hemin
and temperature
Heme [Fe(II)-protoporphyrin IX] and hemin [Fe
(III)-protoporhyrin IX-Cl] are important for the
growth, survival, and virulence of P. gingivalis
[34,35]. P. gingivalis cannot synthesize the protopor-
hyrin IX ring and does not have siderophores for
alternative bioavailability of hemin [36–39].
Therefore, P. gingivalis depends on the host for a
supply of heme [40]. The lysis of multiple erythro-
cytes, in order to feed P. gingivalis heme, would lead
to decrease in oxygen for the host, which would in
turn contribute to ischemia. Therefore, the bacterium
gains advantage for ideal growth conditions.
However, if the supply of hemin is less than adequate,
as tested in vitro, for the pathogen, at least, it is
proposed that the A-LPS lipid A structure of P. gin-
givalis becomes modified according to the hemin
concentration in the growth medium [25]. Different
isoforms of A-LPS have been demonstrated in experi-
ments where P. gingivalis cultures contained either
low or high hemin concentrations (Figure 1(c,d). AtTa
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high hemin concentration, LPS1,435/1,449 (high hemin)
was synthesized, and it elicited a weak immune cell
activation via TLR2. Biochemical analysis of the lipid
A region demonstrated a mono-phosphorylated,
tetra-acylated structure (Figure 1(c)) [25].
Alternatively, P. gingivalis culture from low hemin
concentration, LPS1,690 (low hemin), was found to be
more immunogenic [25]. Biochemical analysis
showed that the LPS activity, surprisingly, was of
antagonist nature with a mono-phosphorylated
penta-acylated lipid A (Figure 1(d)) [25]. It is worth
noting that P. gingivalis LPS1,435/1,439 and LPS1,690
mixtures obtained from culture conditions with high
hemin content also demonstrated a potent immuno-
genic response. These observations, taken together,
suggest that P. gingivalis LPS1,435/1,439/1,690, may
have tools to paralyze the host’s innate defences and
expose tissues to an inflammophilic milieu [41,42].
One advantage of the heterogeneity displayed in P.
gingivalis A-LPS would be that at least it would pro-
vide resistance from septicaemia/endotoxin shock to
the host.
Coats et al. [31] found that P. gingivalis uses endo-
genous lipid A 1 activity to produce a unique non-
phosphorylated lipid in A-LPS. This immunologically
silent lipid A has the capacity to provide a highly
effective mechanism, which is used by this bacterium
to evade TLR4 sensing and to resist killing by cationic
anti-microbial peptides released by the host. As the
lipid A 1-phosphatase activity was suppressed by
hemin, it has been suggested that hemin-dependent
regulation of lipid A 1-dephosphorylation could
change the A-LPS lipid A activity from TLR4 evasive
to TLR4 suppressive. This may alter the critical inter-
action between P. gingivalis, the local microbial com-
munity, and the innate immune system of the host.
Hemin acquisition proteins such as gingipain K
(Kgp) and/or the heme receptor (HmuR) molecules
[25,43] appear to be the sensors of its concentration
in the environment, although other proteins for
hemin binding or its transport may also exist.
A-LPS of P. gingivalis serves as a matrix for the
deposition of µ-oxo-bisheme [[Fe(III)PPIX]2O] and
is accountable for the black pigment seen within these
cells. µ-Oxo-bisheme pigmentation is a form of a
bacteriocin and a virulence factor of P. gingivalis
[40]. Both Arg and Lys gingipains are required for
the deposition of this characteristic black pigment.
Absence of A-LPS in the extracellular surface of P.
gingivalis diminishes the scaffold/anchoring mechan-
ism that otherwise retains Arg- and Lys-gingipains
[40]. This implies that A-LPS serves as a site for
deposition/binding of hemin. Since pigmentation
depends on the presence of A-LPS and Arg- and
Lys-gingipains, these observations suggest a signifi-
cant role of A-LPS in the eventual virulence of P.
gingivalis.
Curtis et al. [32] discovered that P. gingivalis at
normal body temperature mainly produced non-
phosphorylated and mono-phosphorylated tetra-acy-
lated lipid A structures. This phenomenon was tested
by culturing P. gingivalis at higher temperatures (39
or 41°C), so mimicking the conditions at the sites of
periodontal inflammation. This resulted in generating
increased amounts of both mono-phosphorylated and
penta-acylated lipid A. The final nail in the coffin for
P. gingivalis was the activation of the TLR4 at higher
temperatures, which could potentially kill it via β-
defensins 2 and 3 activities. If modification of lipid
A by the host’s body temperature variation affects the
virulence and susceptibility to killing, then this
inflammophilic bacterium may have evolved hidden
mechanisms to thrive under precisely those condi-
tions in vivo.
LPS heterogeneity clarifies earlier
contradictory results related to host innate
immune mediators
It has become apparent that the A-LPS of P. gingi-
valis plays an important role in deregulating the
innate immune system of the host. This is further
achieved by changing the host’s defence signalling
mechanisms through its heterogeneous A-LPS lipid
A structures [31,44]. For example, Herath et al. [4]
observed that the NF-ĸB signalling pathway was
noticeably activated in human gingival fibroblasts
(HGFs) by LPS1,690 but not by LPS1,435/1,449. The
heterogeneity displayed in the A-LPS also modu-
lated the secretion of a different profile of the pro-
inflammatory cytokine expression such as IL-6 and
IL-8 in HGFs [45]. Furthermore, P. gingivalis
LPS1,690 significantly up regulated the expression
of IL-6 and IL-8 mRNA at the gene level in
HGFs, whereas LPS1,435/1,449 failed to do so [45].
In human monocytes, the A-LPS induced produc-
tion of IL-1α, IL-1β, IL-6, and IL-8, although at a
lower rate than that induced by lipid A obtained
from total A-LPS [26]. In addition, pro-inflamma-
tory genes significantly up regulated by LPS1,690
(GM-CSF, CXCL10, G-CSF, IL-6, IL-8, and CCL2)
were down regulated by LPS1,435/1,449 [4] (see
Table 1). HGFs matrix metalloproteinase (MMP)-3
and its protein were strikingly up regulated by
penta-acylated P. gingivalis LPS1,690 and hexa-acy-
lated Escherichia coli LPS but not by tetra-acylated
P. gingivalis LPS1,435/1,449 [30], suggesting plausible
crosstalk between LPS signalling from Gram-nega-
tive pathogens during mixed infections.
Furthermore, human beta-defensins, hBD-1, hBD-
2, and hBD-3 mRNAs, were significantly up regu-
lated in human epithelia by P. gingivalis LPS1,690
but down regulated by LPS1,435/1,449 [46].
Differential signalling pathway activation in various
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cell types [4] helps explain (at least in part) the
contradictory results reported by earlier studies
[28,29] and demonstrates tissue-specific modes of
inflammatory signals initiated essentially by the
same immunogen. The advantage to the keystone
bacterium would likely be in suppressing, some
signalling pathways for adapting to different tissue
environments. This may explain the role P. gingi-
valis plays in establishing disparate organ-specific
inflammatory pathologies.
In human oral keratinocytes (HOKs), P. gingivalis
penta-acylated mono-phosphorylated LPS1,690 has
been shown to act as an agonist for E-selectin expres-
sion, while tetra-acylated mono-phosphoryl struc-
tures LPS1,435/1,449 act as antagonists [47].
Interestingly, structurally similar, penta-acylated,
mono-phosphorylated LPS forms from P. gingivalis
and the genus Bacteroides (from the gastrointestinal
tract) caused vastly different types of innate immune
reactions that were ascribed to subtle differences in
the molecular weight fatty acid content of A-LPS
[48]. This supports further the view that P. gingivalis
A-LPS is unlikely to cause sepsis and formation of
intra-abdominal abscesses in the host.
The different isoforms of LPS can also affect
periodontal pathogenesis by disrupting pattern
recognition receptors (PRRs) such as LPS-binding
protein (LBP) [49,50]. LPS1,435/1,449 down regu-
lated recombinant human (rh) LBP-induced IL-6
and IL-8 mRNAs significantly more than P. gingi-
valis LPS1,690 [50]. P. gingivalis LPS1,690-rh LBP
interaction also caused a dramatic up regulation
of the transcript of the cell surface molecule
CD180 and a significant down regulation of the
myeloid differentiation factor 1 (MD-1) transcript.
This probably occurred through fine-tuning of the
CD180–MD1 complex and appropriate TLRs [50].
LPS1,690 was shown to stimulate LBP in HOKs by
affecting the signalling pathways of NF-ĸB and
p38 MAPK whereas LPS1,435/1,449 was unable to
perform this task [51]. Changing the lipid A struc-
ture of P. gingivalis may, therefore, be a crucial
strategy for this keystone periodontal pathogen to
escape from the hostile innate host defences.
Interestingly, an oral infection in apoliporotein
E knockout (ApoE−/−) mice with a P. gingivalis
strain expressing antagonistic lipid A caused vas-
cular inflammation, macrophage accumulation,
and progression of atherosclerosis [52], whereas a
strain producing agonistic lipid A increased the
levels of pro-inflammatory mediators and acti-
vated the inflammasome in a caspase-11-depen-
dent manner. This led to host cell lysis and
reduced bacterial survival. Thus, P. gingivalis
avoided immune detection and promoted chronic
inflammation in the vasculature. Chronic diseases
may, therefore, be ascribed to pathogen-related
strategies for immune evasion leading to low-
grade inflammation.
Differences in lipid A have different effects on
TLR signalling
The innate immune system senses the invasion of
pathogenic microorganisms via TLRs that recognize
specific PAMPs. Heterogeneity in the P. gingivalis
A-LPS can determine the virulence of this bacterium.
This is seen especially via the elegant experiments
related to hemin bioavailability [25]. Thus, P. gingi-
valis LPS1,435/1,469 and LPS1,690 can modulate TLR2
and/or TLR4 depending on the immediate environ-
mental conditions and the cell type [25,30,47,50] to
facilitate (epithelial/matrix) barrier breakdown for its
access to its eventual periodontal niche. Tetra- and
penta-acylated lipid A structures of P. gingivalis dif-
ferentially activated TLR4-mediated NF-kB signal
transduction and modulated the expression of IL-6
and IL-8 in HGFs [4]. TLR2 and cluster of differen-
tiation (CD) 14 mRNA were regulated differentially
in human gingival epithelia while the modulation of
hBD-2 expression was suggested to occur through co-
operation of both TLR2 and TLR4 [46]. In another
study, multiple lipid A species interacted functionally
with both TLR2 and TLR4 [15]. However, as already
mentioned, the TLR2 agonist activity in P. gingivalis
is most likely due to a lipoprotein, and treatment of
LPS with lipoproteinase as free LPS substantially
attenuated the TLR2 engaging activity [17]. These
findings explain previous observations that P. gingi-
valis LPS can act both as a TLR4 agonist and antago-
nist, with an end result of varying cytokine secretion
profiles [5,11,12]. Also in HOKs, P. gingivalis
LPS1,690-induced LBP expression occurred through
both TLR2 and TLR4 [51], while recombinant rh
LBP significantly up regulated the expression of IL-6
and IL-8 in HOKs through the TLR2 signalling path-
way [50]. These observations repeatedly highlight the
adaptability of P. gingivalis not only to disrupt cell-
specific barriers but also to select the level of potency
conducive to the required inflammophillic milieu and
disease initiation/progression. The shape of the lipid
A component of LPS has been proposed to determine
the physiological functioning of LPS. Conical-shaped
LPS (e.g. from E. coli) may stimulate cells through
TLR4 while cylindrically shaped LPS e.g. from P.
gingivalis may stimulate cytokine production through
TLR2 [53]. Strictly speaking, cylindrical LPS mole-
cules, albeit from other bacterial sources
(Rhodobacter sphaerodides), demonstrate antagonistic
properties at TLR levels. Accordingly, the LPS from
P. gingivalis can act as a TLR2 or TLR4 agonist or
antagonist depending upon the TLR cell type being
activated in the host, or if multiple bacterial lipid A
species are present. The joint signalling pathways
JOURNAL OF ORAL MICROBIOLOGY 5
elicited by TLR2 and TLR4 agonists may diverge to
enable distinct patterns of expression, a property
elicited by P. gingivalis A-LPS heterogeneity.
LPS influences host cell autophagy processes
P. gingivalis often subverts autophagy processes in host
cells in order to survive. In a study by Blasi et al. [54],
variants of P. gingivalis LPS altered lipidation of autop-
hagy protein, i.e. microtubule-associated protein 1
light chain 3 (LC3). Whereas LPS1,690 stimulated pro-
duction of very large autophagic protein LC3-positive
vacuoles and cargo sorting protein MREG puncta in
macrophages, the LPS1,690-mediated LC3 lipidation
was reduced when LPS1,435/1,449 was present. This
indicated that the prevalence of a particular LPS moi-
ety could affect the degradative capacity of host cells,
thereby influencing bacterial survival. This is note-
worthy since peripheral blood mononuclear cells
from periodontitis patients show increased levels of
autophagy-related gene expression and high levels of
mitochondrial reactive oxygen species, with further
increase in LC3 upon stimulation of gingival fibro-
blasts with P. gingivalis LPS [55]. The ability to dysre-
gulate autophagy in phagocytic cells has implications
for development of distant organ inflammatory dis-
eases in which either P. gingivalis or its LPS have been
detected or been tested experimentally [56,57].
A-LPS provides serum resistance to P. gingivalis
P. gingivalis is unique in that it displays commonality
for the biosynthesis of A-LPS and the glycosylation of
Arg gingipains [58]. Given that these two virulence
factors, independently of each other, can be potent
immune effectors in the host, why has P. gingivalis
acquired this co-operation with its LPS and Arg gin-
gipains as well? Experiments conducted with deletion
mutants in the loci porR (PG1138) and wbpB
(PG2119), which are devoid of A-LPS but possess
O-LPS [59,60], exerted less gingipain enzymatic activ-
ity. These loci are, therefore, probably involved in the
biosynthesis of A-LPS [60,61]. Furthermore, the
mutants were susceptible to killing by the comple-
ment system, suggesting that A-LPS has a role in
serum resistance to P. gingivalis [61,62]. Also, in the
non-pigmented P. gingivalis strain HG66, which lacks
A-LPS but possesses O-LPS, a nonsense mutation in
the wbpB gene was detected, and Wbp pathway gene
mutants were found to be A-LPS deficient [60]. Both
penta-acylated lipid A and non-phosphorylated lipid
A failed to activate TLR4 and provided the pro-
nounced ability of these bacteria to resist polymor-
phonuclear neutrophil-mediated killing. The above
experimental outcome suggests that A-LPS and Arg
gingipains may be acting as switches that exert influ-
ence on the endotoxin/exotoxin activity for
maintaining bacterial survival and retaining patho-
genicity. The pigment of this bacterium plays a vital
role in maintaining A-LPS heterogeneity and there-
fore its potent virulence.
A-LPS affects production of OMVs
The main component of the outer leaflet of outer mem-
brane vesicles (OMVs) is LPS, while the inner leaflet
consists of a layer of phospholipids. Rangarajan et al.
[27] suggested a novel mechanism for the production of
OMVs in P. gingivalis implying dephosphorylation of the
lipid A region of A-LPS that is controlled or regulated by
the OM protein PG0027. This may be responsible for
destabilization of the outer membrane followed by bleb-
bing and generation of OMVs. Such an explanation is
based on PG0027, which seems to control the amount of
phosphorylated and non-phosphorylated species of lipid
A in A-LPS, and thereby the production of OMVs in P.
gingivalis. It is also plausible that these vesicles are pro-
duced in regions of the outer membrane enriched in
A-LPS that are devoid of non-phosphorylated lipid A.
Conversely, dephosphorylation of lipid A through a
PG0027-dependent process may be required for optimal
processing of OMVs. The relative proportions of non-
phosphorylated andphosphorylated lipidA are obviously
crucial for outermembrane blebbing and generation inP.
gingivalis.
Biosynthesis of A-LPS and glycosylation of
Arg gingipains share common steps
Gingipains are important virulence factors ofP. gingivalis
in addition to LPS. Genesis of these factors may share
common pathways as suggested previously, in respect to
µ-oxo-bisheme, responsible for the black pigment. Since
a monoclonal antibody (MAb1B5) raised against the
Arg-gingipain RgpA cross-reacted with a cell-surface
polysaccharide of P. gingivalis strain W50 (A-LPS)
[24,63], it was suggested that the maturation pathway of
the Arg-gingipains could be linked to the biosynthesis of
a surface carbohydrate [24]. The cross-reacting APS,
different from the LPS and serotype capsule polysacchar-
ide, was found to be a phosphorylated branch of mannan
backbone. The backbone consisted of α-1,6-linked man-
nose residues, and the side chains of α-1,2-linked man-
nose oligosaccharides of various lengths. One of the side
chains of the repeating unit carried Manα1–2Manα1-
phosphate linked through phosphorous to a mannose
backbone at position 2. This lead to the proposal that
the Manα1–2Manα1-phosphate fragment constitutes
part of the epitope recognized by MAb1B5. This phos-
phorylated branched mannan represented a new poly-
saccharide that appears immunologically connected to
the post-translational additions of Arg-gingipains
[24,63]. Accordingly, there seem to be common steps in
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the biosynthesis of A-LPS and the glycosylation of Arg
gingipains in P. gingivalis.
Dysregulation of the TLR function may cause
adverse pregnancy outcomes
P. gingivalis has been associated with adverse pregnancy
outcomes (APOs) [64,65]. A hemin-rich medium pro-
motes the growth of TLR4 antagonist forms of P. gingi-
valis [25]. This may have consequences for the placenta,
which is a blood-rich tissue with abundance of red blood
cells. The placental environment may, therefore, be rich
in tetra- and penta-acylated residues in the A-LPS of P.
gingivalis [64]. The ability of P. gingivalis to generate two
different isoforms of A-LPS that either activate or antag-
onize TLR4 could be particularly important to themater-
nal–foetal interface [64]. P. gingivalis dysregulation of the
TLR function in uterus, placenta, and foetal membranes
may promote APO [64–67]. In rats, LPS from P. gingiva-
lis increased maternal blood pressure, induced placental
and foetal growth restriction, and increased foetal resorp-
tions, without inducing proteinuria and inflammation
[68]. It is likely, therefore, that P. gingivalis LPS and/or
A-LPS may play a role in pregnancy complications
related to periodontal pathogens.
Concluding remarks
A-LPS of P. gingivalis is remarkably heterogeneous. This
was originally discovered following various biochemical
approaches used to extract LPS. The different isoforms of
LPS varied biochemically because of the methodology
utilized, and the environmental factors experienced dur-
ing their culture, for example presence of hemin and
temperature conditions. Analytical techniques were
instrumental in deducing that P. gingivalis lipid A con-
sists of multiple structures including a phosphorylated
penta-acylated form and a phosphorylated tetra-acylated
form. These species were absent in O-LPS. The fact that
different strains ofP. gingivalis displayed varying capacity
to elicit host inflammatory responses also suggests that
the structure of the major virulence factors O-LPS and
A-LPS could differ. This property is reflected in their
interactions with the PRRs. The variation could actually
be one of multiple strategies that P. gingivalis uses to
evade innate host defence in periodontal tissues, thereby
contributing to periodontal pathogenesis.
The recognition that there are at least two different
forms of P. gingivalis LPS, O-LPS and A-LPS, is signifi-
cant. This is particularly important because A-LPS has
been shown to have important effects on virulence
through its effect on OMV production, serum resistance,
and by serving as a matrix for deposition of µ-oxo-
bisheme on the cell surface. The heterogeneous lipid A
structures may also have distinct and opposing effects on
TLR receptors playing a critical role in the early innate
immune response to invading pathogens. Only subtle
changes in lipid A structures are required to influence
the host immune response to a large extent, and it has
been speculated that P. gingivalis uses the ability of chan-
ging its lipid A composition to paralyze local pro-inflam-
matory cytokine production, thereby gaining access to
periodontal tissue. Although the mechanisms that con-
trol the natural lipid A heterogeneity in P. gingivalis are
not clear, they may exert a form of immunomodulation
that helps P. gingivalis adapt and survive in different host
environments and induce chronic inflammation.
Unfortunately, there is no evidence yet to demon-
strate that a shift in lipid A classes occurs in subgin-
gival plaque samples when comparing healthy/
gingivitis or chronic periodontitis sites. This is a
critical biological correlate required to be demon-
strated before arguments about the importance of
different lipid A classes can be accepted. Lipid A
preparation from wild-type P. gingivalis contains
unphosphorylated and phosphorylated lipid A con-
stituents as well as tetra- and penta-acylated classes.
Considering the documented opposing effects of
these preparations, and the likelihood of the presence
of multiple species within each isolate, it is not clear
how the combinations of lipid A classes affect the
engagement of innate immune receptors in its pri-
mary niche and/or at disparate sites. One possibility
is certain, P. gingivalis is a ‘microbial wizard’ at
adapting to tissue-specific cell receptor signal trans-
duction pathways to colonise niches where growth
conditions may be less than adequate albeit in vitro,
in vivo animals, or the human host. This wizard’s
wand may well be the heretogenity displayed in P.
gingivalis lipid A structures.
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